BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8173579)

  • 1. Graves'-Basedow's disease--asthma association. Presentation of five cases.
    Ursu HI; Pereţianu D; Bulandra T; Cucu C; Grigorie D
    Rom J Endocrinol; 1993; 31(1-2):89-94. PubMed ID: 8173579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reversible pulmonary hypertension in Basedow's disease].
    Nduwayo L; Pop C; Heim J
    Presse Med; 2000 Dec; 29(40):2216-8. PubMed ID: 11196052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basedow's disease].
    Scheidegger K
    Schweiz Rundsch Med Prax; 1993 Aug; 82(32):840-4. PubMed ID: 7690495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroid hormone dynamics during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D; Zhelev N
    Vutr Boles; 1990; 29(1):68-73. PubMed ID: 1697716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical treatment of Basedow's disease: our experience with 424 operations].
    Candela G; Varriale S; Manetta F; Di Libero L; Maschio A; Pizza A; Napolitano S; Santini L
    Chir Ital; 2007; 59(5):707-11. PubMed ID: 18019644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study on the treatment and evolution of Graves' ophthalmopathy.
    Simescu M; Dumitrescu C; Balmeş E; Ursu H; Vaida E; Vârciu M; Voiculescu G; Huţanu M
    Rom J Endocrinol; 1992; 30(3-4):149-58. PubMed ID: 1339521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MANAGEMENT OF ENDOCRINE DISEASE: Predictive scores in autoimmune thyroid disease: are they useful?
    Effraimidis G
    Eur J Endocrinol; 2019 Sep; 181(3):R119-R131. PubMed ID: 31137010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical and laboratory findings in Graves' multinodular type disease].
    Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
    Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Graves-Basedow's disease in childhood and adolescence: clinical and biologic features in 49 patients].
    Pavía Sesma C; Villanueva Lamas J; Torres Lacruz M; Valls Tolosa C; Rodríguez Hierro F; Martín Ramos MR; Mañé Herrero S; Cedó Rigalt J
    An Esp Pediatr; 2000 Jul; 53(1):6-11. PubMed ID: 10998396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytes resided in the thyroid are the main source of TSH-receptor antibodies in Basedow's-Graves' disease?
    Leövey A; Nagy E; Balazs G; Bako G
    Exp Clin Endocrinol; 1992; 99(3):147-50. PubMed ID: 1526264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
    Hoeschel M; Heinze HG
    Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychosomatic aspects of hyperthyroidism with special reference to Basedow's disease. An overview].
    Rodewig K
    Psychother Psychosom Med Psychol; 1993 Aug; 43(8):271-7. PubMed ID: 8378518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioactive iodine ablation therapy: a viable option in the management of Graves' disease in Nigeria.
    Adedapo KS; Fadiji IO; Orunmuyi AT; Onimode Y; Osifo BO
    Afr J Med Med Sci; 2012 Dec; 41 Suppl():193-6. PubMed ID: 23678656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamic thyroid hormone levels during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D
    Vutr Boles; 1988; 27(4):15-8. PubMed ID: 2463711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hyperthyroidism from Graves-Basedow's disease].
    López Rey MC; Aguilar Diosdado M; García Curiel A; Gavilan Villarejo I; Escobar Jiménez L; Girón González JA; Escribano Moriana JC; Millán Nuñez-Cortes J
    An Med Interna; 1993 May; 10(5):211-6. PubMed ID: 7686050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of thyrostatic therapy of hyperthyroidism in patients with Basedow's disease and disseminated autonomy].
    Meng W; Meng S; Hampel R; Ventz M; Männchen E; Weber W; Streckenbach B
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):337-40. PubMed ID: 3129277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features of Patients with Basedow's Disease and High Serum IgG4 Levels.
    Torimoto K; Okada Y; Kurozumi A; Narisawa M; Arao T; Tanaka Y
    Intern Med; 2017; 56(9):1009-1013. PubMed ID: 28458304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.